TIANJIN TIANYAO PHARMACEUTICALS CO., LTD.

Altre lingue Tianjin Tianyao Pharmaceuticals Co., Ltd.

Azioni

600488

CNE000001840

Prezzo di chiusura Shanghai S.E. Altri mercati azionari 00:00:00 07/05/2024			Variaz. 5gg	Var. 1 gen.
4,19 ^CNY	+0,48%		+2,44%	-14,49%

26/04	Tianjin Tianyao Pharmaceuticals Co., Ltd. riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024	CI
25/04	L'unità di Jinyao Pharma ottiene l'approvazione per la commercializzazione della soluzione di Ipratropio Bromuro	MT

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Tianjin Tianyao Pharmaceuticals Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	26/04
Jinyao Pharma's Unit Gets Approval to Market Compound Ipratropium Bromide Solution	25/04
Tianjin Tianyao Pharmaceuticals Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	28/03
Jinyao Pharma Unit's Fluconazole Chloride Passes Regulatory Evaluation	08/03
Jinyao Pharma Unit's Metoclopramide Hydrochloride Injection Passes Regulatory Evaluation	29/02
Jinyao Pharma Unit's Clindamycin Phosphate Passes Drug Regulator's Evaluation	11/01
Jinyao Pharmaceutical's Drugs Chosen for China's Centralized Procurement Bid	08/11
Jinyao Pharmaceutical Gets Nod to Market Travoprost	03/11
Tianyao Pharma’s Brain Injury Drug Passes Generic Drug Consistency Test	02/11
Tianjin Tianyao Pharmaceuticals Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	27/10/23
Jinyao Pharmaceutical Unit's Methylcobalamin Injection Passes Drug Regulator's Evaluation	23/10/23
Jinyao Pharmaceutical Gets Nod to Market Two Raw Drug Materials	12/10/23
Tianjin Tianyao Pharmaceuticals Co., Ltd.(XSSC:600488) added to S&P Global BMI Index	18/09/23
Tianjin Tianyao Pharmaceuticals Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	29/08/23
Jinyao Pharmaceutical Unit's Tumor Drug Passes Regulatory Evaluation	01/08/23
Jinyao Pharmaceutical Gets Nod for Marketing Application of Raw Drug Material	14/07/23
Tianjin Tianyao Pharma Receives 35 Million Yuan in Government Subsidies	29/05/23
Tianyao Pharma Registers Inhalation Drug	23/05/23
Jinyao Pharmaceutical's Unit Gets Nod to Topical Cream's Registration	10/05/23
Tianjin Tianyao Pharmaceuticals Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	27/04/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Tianjin Tianyao Pharmaceuticals Co., Ltd.

Azioni

600488

CNE000001840

Altre lingue

Filtri